Myriad Genetics Inc (NASDAQ:MYGN)

16.62
Delayed Data
As of Sep 22
 -0.15 / -0.89%
Today’s Change
13.92
Today|||52-Week Range
24.21
+14.54%
Year-to-Date

Today’s Trading

Previous close16.77
Today’s open16.76
Day’s range16.43 - 16.76
Volume21,708
Average volume (3 months)523,208
Market cap$1.4B
Data as of 3:59pm ET, 09/22/2023

Growth & Valuation

Earnings growth (last year)-298.51%
Earnings growth (this year)-7.78%
Earnings growth (next 5 years)-68.57%
Revenue growth (last year)-1.77%
P/E ratioNM
Price/Sales1.72
Price/Book1.53

Competitors

----
CLDXCelldex Therapeutics...-0.81-3.09%
VCYTVeracyte Inc-0.11-0.49%
----
Data as of 4:00pm ET, 09/22/2023

Financials

Next reporting dateOctober 31, 2023
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$678.4M
Annual profit (last year)-$112.0M
Net profit margin-16.51%

Profile

Sector
Health Technology
Industry
Medical Specialties
No executives to display
Corporate headquarters
Salt Lake City, Utah

Forecasts